SCHEMBL7070263

SCHEMBL7070263

CCOC(Cc1ccccc1OCc1cnc2ccccc2c1)C(=O)Oc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.38
PDE10A Q9Y233 4/20 0.38
MAOB P27338 3/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
PPARA Q07869 3/20 0.37
PPARG P37231 2/20 0.37
PPARD Q03181 2/20 0.37
MME P08473 1/20 0.37
ACE P12821 1/20 0.37
CPA1 P15085 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
FAAH O00519 2/20 0.37
CCKBR P32239 1/20 0.36
STAT3 P40763 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CGAS Q8N884 1/20 0.35
NOTUM Q6P988 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069482 0.93 MAOB (0.37) SCN9APDE10AMAOBSIRT2PPARA
SCHEMBL7066781 0.90 CYP1A2 (0.42) SCN9APDE10AMAOBSIRT2FAAH
SCHEMBL7069421 0.89 SIRT2 (0.43) SCN9APDE10ASIRT2FAAHHTT
SCHEMBL7069282 0.89 PPARG (0.45) SCN9APDE10APPARAPPARGPPARD
SCHEMBL7070260 0.87 PPARA (0.53) MAOBPPARAPPARGPPARD
SCHEMBL7066564 0.86 MMP1 (0.40) SCN9APDE10AFAAHHTTSMN1; SMN2
SCHEMBL7069687 0.86 PDE10A (0.39) SCN9APDE10AMAOBSIRT2CCKBR
SCHEMBL7069271 0.82 PPARA (0.49) PPARAPPARG
SCHEMBL7069697 0.82 PPARG (0.41) SCN9APDE10ASIRT2PPARAPPARG
SCHEMBL7068772 0.81 PDE10A (0.42) SCN9APDE10ASIRT2MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed
EP-1266888-A1 QUINOLINE DERIVATIVES AND MEDICINAL USE THEREOF Mitsui Chemicals, Inc. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA SCN9A 4160/4885PDE10A 2389/4885MAOB 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.